Shedding light on the mutational landscape of the most common pediatric cancer

Posted by on September 21, 2016 7:56 pm
Categories: health

Genomic alterations have been discovered in pediatric relapsed ALL that cause both therapy resistance and improved clinical response to multi-agent chemotherapy treatment.

Leave a Reply

Your email address will not be published. Required fields are marked *